MYRIAD GENETICS INC — Director's Dealing 2021

Sep 21, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2021-09-17

Reporting Person: Hart Jayne B. (Chief People Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-09-17	Common Stock	M	73225	$26.49	Acquired	153287	Direct
2021-09-17	Common Stock	S	64480	$33.72	Disposed	88807	Direct
2021-09-17	Common Stock	M	3775	$26.49	Acquired	92582	Direct
2021-09-17	Common Stock	S	2966	$33.72	Disposed	89616	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2021-09-17	Incentive Stock Option (right to buy)	$26.49	M	3775	Disposed	2021-09-17	Common Stock (3775)	Direct
2021-09-17	Non-Qualified Stock Option (right to buy)	$26.49	M	73225	Disposed	2021-09-17	Common Stock (73225)	Direct

Footnotes

F1: Represents the net exercise of outstanding stock options. The reporting person received 8,745 shares of common stock on net exercise of options to purchase 73,225 shares of common stock. The company withheld 64,480 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.

F2: Represents the net exercise of outstanding stock options. The reporting person received 809 shares of common stock on net exercise of options to purchase 3,775 shares of common stock. The company withheld 2,966 shares of common stock for payment of the exercise price and tax withholdings, using the closing stock price on September 17, 2021 of $33.72.

F3: The shares subject to this option are fully vested and exercisable.